This page lists the SEC filings reported by DOMAIN PARTNERS IV LP.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2010-01-15 | DOMAIN PARTNERS IV LP | SENORX INC | - | - | EDGAR |
| SC 13G/A | 2009-02-06 | DOMAIN PARTNERS IV LP | SENORX INC | 1,169,067 | 6.7% | EDGAR |
| SC 13G/A | 2008-02-07 | DOMAIN PARTNERS IV LP | Northstar Neuroscience, Inc. | - | - | EDGAR |
| SC 13G | 2008-02-07 | DOMAIN PARTNERS IV LP | SENORX INC | 1,344,783 | 7.8% | EDGAR |
| SC 13G | 2007-02-12 | DOMAIN PARTNERS IV LP | Northstar Neuroscience, Inc. | - | - | EDGAR |
| SC 13G/A | 2006-01-19 | DOMAIN PARTNERS IV LP | NUVASIVE INC | - | - | EDGAR |
| SC 13G/A | 2006-01-13 | DOMAIN PARTNERS IV LP | INTRALASE CORP | - | - | EDGAR |
| SC 13G/A | 2005-01-20 | DOMAIN PARTNERS IV LP | PHARMION CORP | - | - | EDGAR |
| SC 13G | 2005-01-20 | DOMAIN PARTNERS IV LP | NUVASIVE INC | - | - | EDGAR |
| SC 13G | 2005-01-20 | DOMAIN PARTNERS IV LP | INTRALASE CORP | - | - | EDGAR |
| SC 13G | 2004-01-28 | DOMAIN PARTNERS IV LP | PHARMION CORP | - | - | EDGAR |
| SC 13D/A | 2004-01-07 | DOMAIN PARTNERS IV LP | ONYX PHARMACEUTICALS INC | - | - | EDGAR |
| SC 13D | 2002-05-30 | DOMAIN PARTNERS IV LP | ONYX PHARMACEUTICALS INC | - | - | EDGAR |
| SC 13G/A | 2002-01-31 | DOMAIN PARTNERS IV LP | ORAPHARMA INC | - | - | EDGAR |
| SC 13D/A | 2001-10-04 | DOMAIN PARTNERS IV LP | CARDIAC SCIENCE INC | - | - | EDGAR |
| SC 13D/A | 2001-10-01 | DOMAIN PARTNERS IV LP | CARDIODYNAMICS INTERNATIONAL CORP | - | - | EDGAR |
| SC 13D/A | 2001-07-17 | DOMAIN PARTNERS IV LP | AMYLIN PHARMACEUTICALS INC | - | - | EDGAR |
| SC 13G | 2001-02-13 | DOMAIN PARTNERS IV LP | ORAPHARMA INC | - | - | EDGAR |
| SC 13D/A | 2000-09-14 | - | - | - | - | EDGAR |
| SC 13D | 2000-06-26 | - | - | - | - | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.